HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Kate Newberry Selected Research
Kate Newberry Research Topics
Disease
4
Primary Myelofibrosis (Myelosclerosis)
01/2017 - 09/2014
3
Neoplasms (Cancer)
10/2021 - 08/2013
2
Leukemia
01/2017 - 03/2015
2
Mantle-Cell Lymphoma (Lymphoma, Mantle Cell)
06/2014 - 08/2013
1
Disease Progression
10/2021
1
Thrombocytosis (Thrombocythemia)
01/2017
1
Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
03/2015
1
Anemia
09/2014
1
Multiple Myeloma
06/2014
1
Myelodysplastic Syndromes (Myelodysplastic Syndrome)
06/2014
1
Non-Hodgkin Lymphoma (Lymphosarcoma)
08/2013
Drug/Important Bio-Agent (IBA)
2
Janus Kinases
IBA
01/2017 - 03/2015
2
Lenalidomide (CC 5013)
FDA Link
08/2015 - 06/2014
2
ruxolitinib
IBA
08/2015 - 03/2015
1
avapritinib
IBA
10/2021
1
regorafenib
IBA
10/2021
1
Tyrosine Kinase Inhibitors
IBA
10/2021
1
Platelet-Derived Growth Factor Receptors (Platelet-Derived Growth Factor Receptor)
IBA
10/2021
1
Janus Kinase 2
IBA
01/2017
1
Calreticulin
IBA
01/2017
1
L-Lactate Dehydrogenase (Lactate Dehydrogenase)
IBA
08/2015
1
pomalidomide
IBA
09/2014
1
Hemoglobins (Hemoglobin)
IBA
09/2014
1
Prednisone (Sone)
FDA Link
Generic
09/2014
1
ibrutinib
IBA
08/2013
1
Agammaglobulinaemia Tyrosine Kinase
IBA
08/2013
Therapy/Procedure
3
Therapeutics
01/2017 - 09/2014